{"mainPropery":{"diseaseId":8742,"diseaseName":"Limbic encephalitis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/8742/limbic-encephalitis","synonyms":[],"synonyms-with-source":[],"identifiers":[{"identifierType":"ORPHANET","identifierId":"163892"},{"identifierType":"UMLS","identifierId":"C0338430"}]},"diseaseCategories":[],"organizations":[{"resourceID":364,"resourceName":"Encephalitis Society","abbreviation":"","address1":"32 Castlegate","address2":"Malton, North Yorkshire YO17 7DT","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"+44 (0)1653 699599","tty":"","tollFree":"","fax":"","email":"support@encephalitis.info","url":"http://www.encephalitis.info/","freeText":"Social media:\r\nTwitter: @encephalitis\r\nFacebook: /encephalitissociety"},{"resourceID":3767,"resourceName":"International Autoimmune Encephalitis Society","abbreviation":"","address1":"","address2":"","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"United States","phone":"352-527-2470","tty":"","tollFree":"","fax":"","email":"IAES@autoimmune-encephalitis.org","url":"https://autoimmune-encephalitis.org/","freeText":""}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=PureSearch&db=pubmed&details_term=%28limbic%5BTitle%5D%20AND%20encephalitis%5BTitle%5D%29%20AND%20hasabstract%5Btext%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Limbic encephalitis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://www.emedicine.com/neuro/topic300.htm' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=163892' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2093,"resourceId":364,"resourceName":"Encephalitis Society","descriptionText":"The <a href='https://www.encephalitis.info/limbic-encephalitis' target='_blank'>Encephalitis Society</a> offers a factsheet on&nbsp;Limbic encephalitis","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/Orphanet:163892' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2460,"resourceId":3768,"resourceName":"Autoimmune Encephalitis - articles","descriptionText":"Graus F, Titulaer MJ, Balu R, Benseler S et al., <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066574/\" target=\"_blank\">A\r\nclinical approach to diagnosis of autoimmune encephalitis</a>. Lancet Neurol. 2016\r\nApr;15(4):391-404.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":2557,"resourceId":3873,"resourceName":"IAES Diagnosis and Treatment","descriptionText":"The <a href=\"https://autoimmune-encephalitis.org/diagnosis/\" target=\"_blank\">International Autoimmune Encephalitis Society</a> offers patients and families detailed information on diagnosis and treatment.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2558,"resourceId":3875,"resourceName":"IAES Facebook","descriptionText":"<span style=\"font-size: 11.5pt; font-family: Segoe\\ UI, sans-serif; color: #212121;\">The <a target=\"_blank\" href=\"https://www.facebook.com/groups/251477975360/\">International Autoimmune Encephalitis Society Facebook group</a> offers educational support through this forum.</span>","resourceClassificationName":"Organizations","resourceClassificationSectionName":"Social Networking Websites"},{"id":2560,"resourceId":3877,"resourceName":"Paraneoplastic disorder Free Full-text","descriptionText":"Jammoul A, Li Y, Rae-Grant A. <a target=\"_blank\" href=\"https://www.mdedge.com/sites/default/files/issues/articles/Jammoul_Autoantibody-mediatedEncephalitis.pdf\">Autoantibody-Â­mediated encephalitis: Not just paraneoplastic, not just limbic, and not untreatable</a>. Cleveland Clinic Journal of Medicine. 2016 January;83(1):43-53.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"},{"id":2583,"resourceId":3768,"resourceName":"Autoimmune Encephalitis - articles","descriptionText":"Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR. <a href=\"http://jnnp.bmj.com/content/early/2017/10/21/jnnp-2017-315720\" target=\"_blank\">LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes</a>.  J Neurol Neurosurg Psychiatry. 2018 May;89(5):526-534.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"}],"overviewQuestion":{"questionId":654,"questionText":"What is limbic encephalitis?","answerText":"<strong>Limbic encephalitis </strong>represents a group of<strong>&nbsp;</strong><a href=\"https://www.nlm.nih.gov/medlineplus/autoimmunediseases.html\" target=\"_blank\">autoimmune</a> conditions characterized by  inflammation of the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/imagepages/19244.htm\" target=\"_blank\">limbic system</a>&nbsp;and other parts of the brain.&nbsp;The cardinal sign of limbic encephalitis is a severe impairment of short-term memory; however,&nbsp;symptoms may also include confusion, psychiatric symptoms, and <a href=\"http://www.nlm.nih.gov/medlineplus/seizures.html\" target=\"_blank\">seizures</a>.&nbsp;The symptoms&nbsp;typically develop over a few weeks or months, but they may evolve over a few days. Limbic encephalitis is often associated with an underlying <a href=\"http://www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=46264\" target=\"_blank\">neoplasm</a>&nbsp;(paraneoplastic limbic encephalitis); however some cases never have a neoplasm identified (non-paraneoplastic limbic encephalitis). Delayed diagnosis is common, but improvements are being made to assist in early detection. Various tests including imaging studies (<a href=\"https://www.nlm.nih.gov/medlineplus/mriscans.html\" target=\"_blank\">MRI</a>, <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/007341.htm\" target=\"_blank\">PET</a>) laboratory tests (<a href=\"https://labtestsonline.org/understanding/analytes/csf/tab/test\" target=\"_blank\">CSF analysis</a>), and tests that measure the electrical activity of the brain (<a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/003931.htm\" target=\"_blank\">EEG</a>)  may be utilized to confirm a diagnosis. Treatment includes removal of the neoplasm (if identified) and immunotherapy.[432][11340][11341]","dateModified":"2016-04-26T00:00:00"},"basicQuestions":[{"questionId":664,"questionText":"What are the signs and symptoms of limbic encephalitis?","answerText":"Although the symptoms of the condition may vary from person to person, the presenting sign of limbic encephalitis is severe impairment of short-term memory, with most patients having difficulties in recall. <a href=\"https://www.nlm.nih.gov/medlineplus/epilepsy.html\" target=\"_blank\">Epileptic seizures</a> are common and may occur prior to symptoms of memory loss.[11340]&nbsp;A  variety of symptoms may be associated with limbic encephalitis such as anterograde amnesia (the inability to store new memories after the onset of the condition),&nbsp;anxiety, depression, irritability, personality change, acute confusional state, hallucinations and seizures. <br />\r\n<br />\r\nOther possible symptoms may include obsessiveness, hyperthermia (increase in body temperature), weight change, sleep disturbances, <a href=\"https://www.nlm.nih.gov/medlineplus/endocrinediseases.html\" target=\"_blank\">endocrine dysfunction</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/aphasia.html\" target=\"_blank\">aphasia</a>, and <a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/007472.htm\" target=\"_blank\">apraxia</a>.[431][11340] The symptoms associated with limbic encephalitis can develop over a few days, weeks, or months. It is important to note the neurological symptoms generally precede diagnosis of the malignancy in 60%-75% of patients that have paraneoplastic limbic encephalitis.[432]","dateModified":"2016-05-11T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":431,"authors":"Voltz R","articleTitle":"Neuropsychological symptoms in paraneoplastic disorders","bookWebsiteJournalTitle":"J Neurol","date":"(2007)","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/17503138","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":432,"authors":"Anderson NE, Barber PA","articleTitle":"Limbic encephalitis - a review","bookWebsiteJournalTitle":"Journal of Clinical Neuroscience","date":"2008","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/18411052","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11340,"authors":"Asztely F, Kumlien E.","articleTitle":"The diagnosis and treatment of limbic encephalitis","bookWebsiteJournalTitle":"Acta Neurol Scand","date":"Dec 2012","volume":"126(6)","pages":"365-375","url":"http://www.ncbi.nlm.nih.gov/pubmed/22713136","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":663,"questionText":"What causes limbic encephalitis?","answerText":"Limbic encephalitis is thought to be caused by a reaction of the immune system to various stimuli such as cancers, tumors, infections, and generalized autoimmune disorders.[11341] In many patients, limbic encephalitis is associated with a tumor or cancer. This is known as paraneoplastic limbic encephalitis (PLE). PLE is most commonly associated with <a href=\"http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/Patient\" target=\"_blank\">small cell lung cancer</a>&nbsp;(SCLC), which is present in 40% of cases. It may additionally be associated with&nbsp;<a href=\"http://www.cancer.gov/cancertopics/types/breast\" target=\"_blank\">breast cancer</a>,&nbsp;<a href=\"http://www.cancer.gov/types/testicular\" target=\"_blank\">testicular cancer</a>, and nearly any other tumor.[431][11340] Limbic encephalitis can also occur in the absence of cancer, known as non-paraneoplastic limbic encephalitis (NPLE), such as in the case of a viral infection (for example <a href=\"https://www.nlm.nih.gov/medlineplus/herpessimplex.html\" target=\"_blank\">herpes simplex virus</a>) or&nbsp;<a href=\"http://www.nlm.nih.gov/medlineplus/autoimmunediseases.html\" target=\"_blank\">systemic autoimmune disorders</a>. In some instances, the cause of limbic encephalitis may never be determined.[11340][11341]","dateModified":"2016-05-12T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":431,"authors":"Voltz R","articleTitle":"Neuropsychological symptoms in paraneoplastic disorders","bookWebsiteJournalTitle":"J Neurol","date":"(2007)","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/17503138","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11340,"authors":"Asztely F, Kumlien E.","articleTitle":"The diagnosis and treatment of limbic encephalitis","bookWebsiteJournalTitle":"Acta Neurol Scand","date":"Dec 2012","volume":"126(6)","pages":"365-375","url":"http://www.ncbi.nlm.nih.gov/pubmed/22713136","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11341,"authors":"Dr Sarosh R Irani, Dr Camilla Buckley and Prof Angela Vincent","articleTitle":"Limbic Encephalitis","bookWebsiteJournalTitle":"The Encephalitis Society","date":"August 2013","volume":"","pages":"","url":"http://www.encephalitis.info/files/9413/3995/5695/FS013V1.pdf","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":10655,"questionText":"How is limbic encephalitis diagnosed?","answerText":"<p>Diagnosis of limbic encephalitis can be made when all three of the following criteria have been met:[14588]\r\n<br />\r\n<br />\r\n1.\tSubacute onset (rapid progression of less than 3 months) of working memory deficits (short-term memory loss), altered mental status, or psychiatric symptoms\r\n<br />\r\n<br />\r\n2.\tAt least one of the following:\r\n<br />\r\n<br />\r\n&nbsp;&nbsp;\r\n&bull;\tNew focal CNS findings\r\n<br />\r\n&nbsp;&nbsp;\r\n&bull;\tSeizures not explained by a previously known seizure disorder\r\n<br />\r\n&nbsp;&nbsp;\r\n&bull;\tCSF pleocytosis (white blood cell count of more than five cells per mm3)\r\n<br />\r\n&nbsp;&nbsp;\r\n&bull;\tMRI features suggestive of encephalitis<br />\r\n<br />\r\n3.\tReasonable exclusion of alternative causes<br />\r\n<br />\r\nExamples of conditions that must be ruled out before a diagnosis of limbic encephalitis can be made, include:[11492]</p>\r\n<ul>\r\n    <li>Infection (<a href=\"https://www.nlm.nih.gov/medlineplus/herpessimplex.html\" target=\"_blank\">herpes simplex virus</a>, <a href=\"https://www.nlm.nih.gov/medlineplus/cytomegalovirusinfections.html\" target=\"_blank\">cytomegalovirus</a>, <a href=\"http://www.cdc.gov/adenovirus/\" target=\"_blank\">adenovirus</a>, <a href=\"https://www.aids.gov/hiv-aids-basics/hiv-aids-101/what-is-hiv-aids/\" target=\"_blank\">HIV</a>)</li>\r\n    <li><a href=\"http://www.ninds.nih.gov/disorders/acute_encephalomyelitis/acute_encephalomyelitis.htm\" target=\"_blank\">Acute disseminating encephalomyelitis</a> (ADEM)&nbsp;</li>\r\n    <li>Degenerative diseases (<a href=\"https://rarediseases.info.nih.gov/gard/6956/creutzfeldt-jakob-disease/resources/1\" target=\"_blank\">Creutzfeldt-Jakob disease</a>, rapidly progressing <a href=\"https://rarediseases.info.nih.gov/gard/10254/alzheimer-disease/resources/1\" target=\"_blank\">Alzheimer disease</a>)</li>\r\n    <li>Nutritional deficiencies (<a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682586.html\" target=\"_blank\">thiamine</a> deficiency)</li>\r\n    <li>Recreational drugs/alcohol</li>\r\n    <li>Metabolic disturbances</li>\r\n    <li>Connective tissue disorders (<a href=\"https://www.nlm.nih.gov/medlineplus/ency/article/000435.htm\" target=\"_blank\">systemic lupus erythematosus</a>)</li>\r\n    <li>Primary or secondary tumor of the central nervous system</li>\r\n</ul>\r\nA team of leading autoimmune encephalitis researchers have established diagnostic criteria for limbic encephalitis. View the full position paper, entitled <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066574/#BX1\">A Clinical Approach to Diagnosis of Autoimmune Encephalitis</a>.<br />\r\n<br />\r\nFor more on diagnosis, visit the following link to the International Autoimmune Encephalitis Society Web site:<br />\r\n<a href=\"https://autoimmune-encephalitis.org/diagnosis/\" target=\"_blank\">https://autoimmune-encephalitis.org/diagnosis</a>","dateModified":"2019-08-05T00:00:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":11340,"authors":"Asztely F, Kumlien E.","articleTitle":"The diagnosis and treatment of limbic encephalitis","bookWebsiteJournalTitle":"Acta Neurol Scand","date":"Dec 2012","volume":"126(6)","pages":"365-375","url":"http://www.ncbi.nlm.nih.gov/pubmed/22713136","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11492,"authors":"F Graus, J Delattre, J Antoine, J Dalmau, B Giometto, W Grisold, J Honnorat, P Smitt, C. Vedeler, J Verschuuren, A Vincent, R Voltz","articleTitle":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","bookWebsiteJournalTitle":"J Neurol Neurosurg Psychiatry","date":"August 2004","volume":"75(8)","pages":"1135-1140","url":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1739186/","dateAccessed":"2016-05-12T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":665,"questionText":"How might limbic encephalitis be treated?","answerText":"Treatment for limbic encephalitis varies depending on the underlying cause. In cases of confirmed paraneoplastic limbic encephalitis (PLE), removal or treatment of the tumor is often the first step in treatment. If the cause of limbic encephalitis is a viral infection, an antiviral&nbsp;drug&nbsp;may be prescribed. <a href=\"http://www.cancer.gov/about-cancer/treatment/types/immunotherapy\" target=\"_blank\">Immunotherapy</a>&nbsp;is often utilized as a first line or second line treatment.[433][11340] If immunotherapy fails, medications such as <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a607038.html\" target=\"_blank\">rituximab</a> or <a href=\"https://www.nlm.nih.gov/medlineplus/druginfo/meds/a611044.html\" target=\"_blank\">cyclophosphamide</a> may be considered.[11340]","dateModified":"2016-05-12T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":433,"authors":"Tuzun E, Dalmau J","articleTitle":"Limbic Encephalitis and Variants:  Classification, Diagnosis, and Treatment","bookWebsiteJournalTitle":"The Neurologist","date":"2007"},{"referenceId":11340,"authors":"Asztely F, Kumlien E.","articleTitle":"The diagnosis and treatment of limbic encephalitis","bookWebsiteJournalTitle":"Acta Neurol Scand","date":"Dec 2012","volume":"126(6)","pages":"365-375","url":"http://www.ncbi.nlm.nih.gov/pubmed/22713136","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":666,"questionText":"What is the long-term outlook for limbic encephalitis?","answerText":"The prognosis for limbic encephalitis varies from person to person and is based on the underlying cause of the condition. For example, individuals that have&nbsp;<a href=\"http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/Patient\" target=\"_blank\">small cell lung carcinoma (SCLC)</a>&nbsp;and test positive for an <a href=\"antibody\" target=\"_blank\">antibody</a> called anti-Hu, tend to respond poorly to treatment, whereas individuals that have an ovarian <a href=\"http://www.cancer.gov/Templates/db_alpha.aspx?CdrID=44248\" target=\"_blank\">teratoma</a> and test positive for the NMDAR antibody respond well to treatment.[432] <br />\r\n<br />\r\nGiven evidence that paraneoplastic limbic encephalitis may occur prior to identification of a tumor, if a tumor is not initially identified, regular tumor screening may be recommended to occur after treatment is completed.[11340]","dateModified":"2016-05-12T00:00:00","resourceClassificationName":"Prognosis","references":[{"referenceId":432,"authors":"Anderson NE, Barber PA","articleTitle":"Limbic encephalitis - a review","bookWebsiteJournalTitle":"Journal of Clinical Neuroscience","date":"2008","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/pubmed/18411052","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":11340,"authors":"Asztely F, Kumlien E.","articleTitle":"The diagnosis and treatment of limbic encephalitis","bookWebsiteJournalTitle":"Acta Neurol Scand","date":"Dec 2012","volume":"126(6)","pages":"365-375","url":"http://www.ncbi.nlm.nih.gov/pubmed/22713136","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[{"relatedDiseaseId":13406,"relatedDiseaseName":"Limbic encephalitis with LGI1 antibodies","relation":"Child","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Limbic_encephalitis"}